• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Edgewise Therapeutics, Inc. - Common Stock (NQ:EWTX)

    30.50 -0.14 (-0.44%)
    Streaming Delayed Price Updated: 2:43 PM EDT, Apr 28, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,320,836
    Open 30.94
    Bid (Size) 30.49 (900)
    Ask (Size) 30.53 (100)
    Prev. Close 30.64
    Today's Range 30.45 - 32.47
    52wk Range 12.15 - 35.00
    Shares Outstanding 105,341,296
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Why Edgewise Therapeutics Stock Topped the Market on Tuesday ↗
    One analyst tracking the biotech has become notably more bullish on its future. 
    Via The Motley Fool
    News headline image
    This Investor Sold $5 Million of a Biotech Stock Up 118% in a Year, but Here's Why It Still Seems Bullish on Shares ↗
    This biotech firm develops therapies targeting cystic fibrosis, with shares up nearly 90% year-over-year as of the latest filing. 
    Via The Motley Fool

    Performance

    YTD
    +28.4%
    +28.4%
    1 Month
    +0.7%
    +0.7%
    3 Month
    +8.9%
    +8.9%
    6 Month
    +90.3%
    +90.3%
    1 Year
    +94.5%
    +94.5%

    More News

    Read More
    News headline image
    This Investor Built a $56 Million Position in RAPT Last Quarter. It Was Just Acquired for $58 Per Share ↗
    Via The Motley Fool
    News headline image
    ORBIMED Advisors Trims $125 Million Terns Stake After a Breakout Year, According to SEC Filing ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Xenon Stock at $42: What to Know of a $75 Million Trim Ahead of March Phase 3 Data ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Inside a $58 Million Bet on Kodiak Amid $184 Million Offering and Phase 3 Readouts Ahead ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    This Fund Just Disclosed a New $55 Million Bet on Centessa Amid 53% Stock Rally and CEO Transition ↗
    Via The Motley Fool
    News headline image
    CG Oncology Soars 102% in a Year, but One Investor Just Disclosed a $58.5 Million Sale ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    BrightSpring Stock Up 86% as Braidwell Takes $45 Million Stake in Healthcare Services Provider ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    MoonLake Stock Soars As Biotech Fund Reloads, Takeover Chatter Ignites ↗
    Via Stocktwits
    News headline image
    Why Edgewise Therapeutics Stock Crushed the Market on Monday ↗
    Via The Motley Fool
    News headline image
    This Biotech Fund Exited an $8 Million Edgewise Stake as the Stock Slid Double Digits ↗
    Via The Motley Fool
    News headline image
    Why Edgewise Therapeutics Stock Rocked the Market Today ↗
    Via The Motley Fool
    News headline image
    Let's take a look at the stocks that are in motion in today's session. ↗
    Via Chartmill
    News headline image
    Edgewise Therapeutics Stock Jumps After Trial Update For Genetic Heart Disease — Wall Street Eyes A Potential Standout ↗
    Via Stocktwits
    News headline image
    Capricor Therapeutics (NASDAQ: CAPR) Soars 535% to Eight-Year High on Landmark Duchenne Muscular Dystrophy Treatment Results
    Via MarketMinute
    News headline image
    This Biotech Fund Just Dumped $14.8 Million in MBX Biosciences — Right Before Key 2026 Milestones ↗
    Via The Motley Fool
    Topics Initial Public Offering Regulatory Compliance
    News headline image
    Biotech Fund Reveals $15 Million MoonLake Exit After Stock’s 90% Crash ↗
    Via The Motley Fool
    Topics Lawsuit Regulatory Compliance
    News headline image
    Biotech Fund Reveals $15 Million MoonLake Exit After Stock’s 90% Crash ↗
    Via The Motley Fool
    Topics Lawsuit Regulatory Compliance
    News headline image
    This Biotech Fund Just Dumped $14.8 Million in MBX Biosciences — Right Before Key 2026 Milestones ↗
    Via The Motley Fool
    Topics Initial Public Offering Regulatory Compliance
    News headline image
    Biotech Fund Dumps $12.3 Million in Crinetics Stock as Shares Remain 19% Lower on the Year ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    Edgewise Therapeutics Inc (NASDAQ:EWTX) Q2 2025 Earnings: EPS Beat Sparks 5% Pre-Market Rally ↗
    Via Chartmill

    Frequently Asked Questions

    Is Edgewise Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Edgewise Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Edgewise Therapeutics, Inc. - Common Stock trade on?
    Edgewise Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Edgewise Therapeutics, Inc. - Common Stock?
    The ticker symbol for Edgewise Therapeutics, Inc. - Common Stock is EWTX on the Nasdaq Stock Market
    What is the current price of Edgewise Therapeutics, Inc. - Common Stock?
    The current price of Edgewise Therapeutics, Inc. - Common Stock is 30.50
    When was Edgewise Therapeutics, Inc. - Common Stock last traded?
    The last trade of Edgewise Therapeutics, Inc. - Common Stock was at 04/28/26 02:43 PM ET
    What is the market capitalization of Edgewise Therapeutics, Inc. - Common Stock?
    The market capitalization of Edgewise Therapeutics, Inc. - Common Stock is 3.21B
    How many shares of Edgewise Therapeutics, Inc. - Common Stock are outstanding?
    Edgewise Therapeutics, Inc. - Common Stock has 3B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.